Last updated: 2026-09-16 14:41:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Envoy Medical, Inc. (COCH) operates in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES sector and is listed on NASDAQ. The stock is currently priced at $0,71, with a market capitalisation of $56,51M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0,36 to $1,89. This page covers its latest market performance, valuation, price trends and company information.
$56,51M | |
$0,71 | |
$11,46 | |
$0,36 | |
$0,71 | |
11,90K | |
368,13K | |
-- | |
$1,89 | |
$0,36 | |
-- | |
-- |
Envoy Medical, Inc. (COCH) is currently trading at $0,71 as of 2026-09-16 14:39:00, up 0,14% ($0,00) from the previous close of $0,71
During today's regular trading session, COCH has traded between $0,36 and $11,46, with a trading volume of 11,90K shares. The current price is near the lower end of today's range.
Over the past seven days, Envoy Medical, Inc. (COCH) moved from $0,71 to $0,71, representing a gain of 0,14% ($0,00).
The stock traded between $0,69 and $0,76 during the period. The latest price is near the lower end of the 7-day range, indicating range-bound.
The average daily volume was 46,62 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 22,8%
COCH is currently trading at $0,71, placing it 22,8% of the way from its 52-week low of $0,36 to its 52-week high of $1,89. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
| Industry | ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES |
| Employees | 47 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Envoy Medical, Inc. (COCH) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.